Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study

This study will help characterize the risk –benefit profile of gepotidacin for treating uncomplicated urogenital gonorrhea. Gepotidacin is an important potential treatment for gonorrhea to help address the urgent unmet need of multidrug resistance and the increasingly limited number of oral treatment options.Trial RegistrationClinicalTrials.gov identifier, NCT04010539.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research